Fundz Deep Dive
Everything you need to win Ocugen — in one platform.
Who to reach, what to say, and why now on Ocugen — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Ocugen — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Ocugen, Inc. Announces Pricing of $35 Million Public Offering of Common Stock
Aug 01, 2024•almost 2 years ago
Contract Type
partnership
MalvernBiotechnologyHealthcareHealth CareTherapeuticsDescription
Ocugen, Inc. has announced the pricing of its underwritten public offering of 30,434,783 shares of its common stock at an offering price of $1.15 per share for gross proceeds of $35 million. The net proceeds from the offering will be used for general corporate purposes, capital expenditures, working capital, and general and administrative expenses.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months